OBJECTIVES: Widespread acceptance of the COVID-19 vaccine will be the next important step in fighting the novel coronavirus disease. Though the Pakistani government has successfully implemented robust policies to overcome the COVID-19 pandemic; however, studies assessing public intention to get COVID-19 vaccination (IGCV) are limited. The aim of this study is to deal with this literature gap and has also expanded the conceptual framework of planned behaviour theory. We have introduced three new considerations (risk perceptions of the pandemic, perceived benefits of the vaccine, and unavailability of vaccine) to have a better understanding of the influencing factors that encourage or discourage public IGCV. METHODS: Results are based on a sample collected from 754 households using an inclusive questionnaire survey. Hypotheses are tested by utilizing the structural equation modelling approach. RESULTS: The results disclose that the intention factors, that is, attitude, risk perceptions of the pandemic, and perceived benefits of the vaccine, impart positive effects on public IGCV. In contrast, the cost of the vaccine and the unavailability of the vaccine have negative effects. Notably, environmental concern has an insignificant effect. CONCLUSIONS: Research findings emphasize the importance of publicizing the devastating impacts of COVID-19 on society and the environment, ensuring vaccination availability at an accessible price while simultaneously improving public healthcare practices.
Assessment of public intention to get vaccination against COVID-19: Evidence from a developing country.
评估公众接种新冠疫苗的意愿:来自发展中国家的证据
阅读:5
作者:Irfan Muhammad, Shahid Abdul Latif, Ahmad Munir, Iqbal Wasim, Elavarasan Rajvikram Madurai, Ren Siyu, Hussain Abid
| 期刊: | Journal of Evaluation in Clinical Practice | 影响因子: | 2.100 |
| 时间: | 2022 | 起止号: | 2022 Feb;28(1):63-73 |
| doi: | 10.1111/jep.13611 | 疾病类型: | 新冠 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
